OTIS ANNUAL RESEARCH MEETING JUNE 2010 Vaccines and Medications in Pregnancy Surveillance System (VAMPSS)
Jan 02, 2016
OTIS ANNUAL RESEARCH MEETING JUNE 2010
Vaccines and Medications in Pregnancy Surveillance
System (VAMPSS)
Background
VAMPSS is sponsored & coordinated by the American Academy of Allergy Asthma &
Immunology and includes two data collection arms and a standing advisory committee
Prospective registry surveillance: OTISCase-Control Surveillance: Slone Epidemiology
Center at Boston UniversityIndependent advisory committee (biostatistician,
reproductive epidemiologist, consumer representative, CDC, NICHD, NHLBI, NIAID, and AAP)
Purpose
The purpose of VAMPSS is to comprehensively monitor the use and safety of flu vaccines and antiviral medications used to treat or prevent
the flu during pregnancy.
VAMPSS Cohort Study Totals
Group Total Enrolled
Recruitment Goal
Seasonal Flu Vaccine 250 300
H1N1 Vaccine 352 300
Antivirals 34 200
Controls 40 300
Total Cohort 411 1100
Who Should be Referred?
Essentially all pregnant women.Specifically:Pregnant women who received a flu vaccine
during pregnancy.Pregnant women who were exposed to an
anti-viral medication to treat or prevent the flu during pregnancy.
Non-exposed controls (pregnant women who have not received any flu vaccines during pregnancy or taken any antivirals while pregnant).